Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Kidney stones, a prevalent condition in urinary tract disorders, continue to pose significant health concerns globally. The steady growth of the global kidney stone market reflects the ongoing challenges posed by this condition, with projections indicating a compound annual growth rate (CAGR) of 4.0% between 2016 and 2022. Several pivotal factors drive this growth trajectory, reshaping the landscape of kidney stone treatment and management.
One of the key drivers contributing to this expansion is the evolution of minimally invasive procedures for treating kidney stones. Advancements in medical technology have revolutionized treatment approaches, offering less invasive methods such as shock wave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy. These procedures minimize patient discomfort, reduce recovery times, and enhance treatment efficacy, thereby fueling the demand for kidney stone management options globally.
Another significant factor propelling the growth of the kidney stone market is the escalating incidence of urolithiasis, particularly among the adult population. Factors such as sedentary lifestyles, dietary habits, and inadequate hydration contribute to the formation of kidney stones. Poor nutrition, characterized by high intake of sodium, protein, and oxalate-rich foods, significantly increases the risk of developing these stones. Consequently, the rising prevalence of these risk factors contributes to the growing incidence of kidney stones, necessitating greater emphasis on effective treatment and preventive measures.
The market's projected growth to reach $3,000 million by 2022, from $2,175.2 million in 2015, underscores the substantial economic impact and the increasing demand for interventions addressing kidney stone-related complications. This growth projection reflects not only the prevalence of the condition but also the investments in research and development aimed at innovative treatment modalities and preventative strategies. Moreover, the market expansion signifies a collective effort by healthcare providers and stakeholders to address the rising burden of kidney stone disorders on global healthcare systems.
As the understanding of the pathophysiology of kidney stones improves and technological advancements continue to redefine treatment paradigms, the market for kidney stone management is poised for further evolution. Greater awareness campaigns promoting lifestyle modifications, dietary adjustments, and hydration practices as preventive measures are crucial in mitigating the incidence of kidney stones. The synergy between technological innovation, preventive healthcare, and patient education remains pivotal in curbing the prevalence of kidney stones while providing more effective and less invasive treatment options for those affected.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Size Value In 2022 | USD 2.20 Billion |
| Market Size Value In 2023 | USD 2.30 Billion |
| Growth Rate | 4.3% (2023-2032) |
Kidney Stones Market Highlights:
Global Kidney Stone Market Overview
Kidney Stone Market Size was valued at USD 2.20 billion in 2022. The Kidney Stone Market industry is projected to grow from USD 2.30 Billion in 2023 to USD 3.9 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.3% during the forecast period (2024 - 2032). Growing adoption of minimally invasive stone removal procedures, and advancements in ureteroscopy techniques are the key market drivers boosting the growth of the kidney stone market.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Kidney Stone Market Trends
- Growing Adoption of Minimally Invasive Stone Removal Procedures to Boost the Market Growth
The rapid adoption of Minimally Invasive Surgical (MIS) techniques by surgeons has led to a wide variety of applications. In general surgery, minimally invasive methods are being adopted more often than open surgeries. The minimal side effects of MIS procedures compared to open surgery will increase the demand for advanced procedures to manage kidney stones. The journal Advances in Chronic Kidney Diseases states that minimally invasive treatments have been widely used for three of the most common stone diseases in America extracorporeal, ureteroscopic, and percutaneous renal lithotomy. Procedures that were previously open to the public are now being performed by minimally invasive surgeons.
Kidney Stone Market Segment Insights
Kidney Stone Type Insights
The kidney stone market segmentation, based on type, includes calcium oxalate stones, uric acid, struvite kidney stones, cystine stones, and calcium phosphate stones. The calcium oxalate stones type segment held the majority share in 2022 with respect to the kidney stone market revenue. This is primarily owing to the high level of oxalate in the urine and lesser intake of water. Also, various risk factors including intake of a diet containing high levels of protein, oxalate, sodium, or sugar may result in calcium oxalate stones formation.
June 2022 Dornier MedTech and Endoluxe signed a multi-year exclusive distribution contract. Dornier and Endoluxe provide products and systems targeted toward the urology market, offering innovation and value
Kidney Stone Treatment Type Insights
The kidney stone market segmentation, based on treatment type, includes medications, extracorporeal shock wave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy. The ureteroscopy segment dominated the market in 2022 with respect to the kidney stone market revenue. This is due to the offering to break up stones, take out suspicious-looking tissue, and have an unobstructed urinary tract view.
Kidney Stone Diagnosis Insights
The kidney stone Market segmentation, based on diagnosis includes ultrasound, intravenous pyelography, CT scan, x-ray, and others. Ultrasound held the largest market share in 2022 with respect to the kidney stone market revenue. This is attributed to the no exposure to radiation, the growing popularity, and the showing of anatomical detail of the kidney in a very less time. It is a safe and painless test that uses sound waves to make images of the kidneys, ureters, and bladder.
September 2019 Dornier MedTech (Dornier), a urology firm and expert in kidney stone therapy, introduced the innovative OptiVision technology for the Dornier Delta III. It is the first imaging system that uses post-processing made exclusively to enhance stone therapy results. Urologists can visualize stones more clearly with OptiVision during extracorporeal shock wave lithotripsy (ESWL) procedures
Figure 2 Kidney Stone Market, by Diagnosis, 2022 & 2030 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Kidney Stone Regional Insights
By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. North America kidney stone held the largest market share in 2022. This is attributed to the developed healthcare infrastructure, favorable government policies, and presence of major key companies headquarters in the region are driving the market in the region. Additionally, it is projected that supportive government measures and an increase in research collaborations will accelerate industry development.
Further, the major countries studied are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3 KIDNEY STONE MARKET SIZE BY REGION 2022 & 2030 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe kidney stone market accounts for the second-largest market share due to the increasing prevalence of kidney stone disease and the rise in the elderly population across Europe. However, the lack of awareness regarding renal stones hinders market growth. Further, the Germany kidney stone market held the largest market share, and the UK kidney stone market was the fastest-growing market in the European region.
The Asia-Pacific kidney stone market is expected to grow at a significant growth rate during the forecast period. This is due to the rising incidence of kidney stones, the rapidly building healthcare infrastructure, the growing government support, and the rising number of startups in this region. Moreover, China kidney stone market held the largest market share, and the India kidney stone market was the fastest-growing market in the Asia-Pacific region. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2023–2030.
Kidney Stone Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the kidney stone market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the kidney stone industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the kidney stone industry to benefit clients and expand the kidney stone market sector is to manufacture locally to reduce operating costs.
Boston Scientific Corporation (US) is a worldwide developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. The company collaborates with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, and increase efficiencies. Its product portfolio is majorly divided into endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology & pelvic health. In September 2021, Boston Scientific Corporation acquired a surgical business of Lumenis Ltd. (Israel) a privately held company that develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA). The Lumenis surgical business includes premier laser systems, fibers, and accessories used for urology and otolaryngology procedures.
Key Companies in the Kidney Stone Market Includes
- Stryker Corporation (US)
- Convergent Laser Technologies (US)
- Boston Scientific Corporation (US)
- Cook Medical Inc. (US)
- DirexGroup (US)
- Siemens Healthcare GmbH (Germany)
- Bard Inc. (US)
- Dornier MedTech GmbH (Germany)
- Olympus Corporation (Japan)
- Richard Wolf GmbH (US)
Kidney Stone Industry Developments
June 2022 Olympus, a technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the launch of the SoltiveTM SuperPulsed Laser System, a new thulium fiber laser application designed for stone lithotripsy and soft tissue applications
June 2020 Boston Scientific Corporation announced that it had entered into a binding deal with Synergy Innovation to acquire the majority investment in M.I Tech Co., Ltd, ( South Korea) a publicly traded Korean manufacturer and distributor of endoscopic and urologic medical devices
Kidney Stone Market Segmentation
Kidney Stone Type Outlook
- Calcium Oxalate Stones
- Uric Acid
- Struvite Kidney Stones
- Cystine Stones
- Calcium Phosphate Stones
Kidney Stone Treatment Type Outlook
- Medications
- Extracorporeal Shock Wave Lithotripsy
- Ureteroscopy
- Percutaneous Nephrolithotomy
Kidney Stone Diagnosis Outlook
- Ultrasound
- Intravenous Pyelography
- CT Scan
- X-Ray
- Others
Kidney Stone Regional Outlook
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
